Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

22.86 +0.04 (+0.15%)
Streaming Delayed Price Updated: 11:03 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,441,081
Open 22.74
Bid (Size) 22.86 (23)
Ask (Size) 22.87 (80)
Prev. Close 22.83
Today's Range 22.64 - 22.98
52wk Range 20.91 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 7.52%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment
Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall. 
Via Benzinga
Exposures COVID-19 Product Safety
Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny
The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to people 65 and older and those 12 and up with underlying health conditions... 
Via Benzinga
Exposures COVID-19 Product Safety

Performance

YTD
-14.1%
-14.1%
1 Month
+3.7%
+3.7%
3 Month
-10.5%
-10.5%
6 Month
-8.0%
-8.0%
1 Year
-19.9%
-19.9%

More News

Read More
India Market Watch: Muted Start For Nifty, Sensex — Defense Stocks, Delhivery Shine
Via Stocktwits
1 Profitable Stock on Our Watchlist and 2 to Turn Down
Via StockStory
Novavax Wins FDA Approval For COVID-19 Vaccine: Retail Calls For Buyback And Bigger Moves
Via Stocktwits
Exposures COVID-19 Product Safety
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
Via The Motley Fool
Exposures COVID-19
Analyst Ethan Billings shares insights on tech stocks
Via Binary News Network
Topics Artificial Intelligence Initial Public Offering
Exposures Artificial Intelligence Securities Market
Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
3 Profitable Stocks to Research Further
Via StockStory
Why Pfizer Is Poised For A Strong Comeback: My Top Pick For 2025
Via Benzinga
What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks
Via The Motley Fool
Topics Economy Government
Exposures Interest Rates Political
3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever
Via The Motley Fool
Topics Economy Stocks World Trade
Exposures Economy Tariff US Equities
Curious about the most active S&P500 stocks in today's session?
Via Chartmill
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Via Benzinga
3 Value Stocks Facing Headwinds
Via StockStory
Jim Cramer Is 'OK' With Harrow, Recommends Buying This Energy Stock
Via Benzinga
PFE Q1 Earnings Call: Revenue Misses, Margin Expansion, and Focus on Pipeline Productivity
Via StockStory
Topics World Trade
Exposures Tariff
Market Monitor News May 12 ( NRG Energy, Amazon, Meta Platforms UP - CVS Health DOWN)
Via Chartmill
Topics Government World Trade
Exposures Political Tariff
Which S&P500 stocks are the most active on Monday?
Via Chartmill
Ford’s Cologne Workers To Strike On Wednesday, Says Report: Retail Sentiment Sours
Via Stocktwits
Topics Government
Exposures Political
KindlyMD Stock Surges To All-Time High After Announcing Merger With Nakamoto To Launch Bitcoin Treasury Strategy
Via Stocktwits
Topics Government Regulatory Compliance
Exposures Legal Political Regulatory
Merck, Pfizer, Eli Lilly Stocks Rebound As Trump Targets Drug Costs With New Executive Order
Via Stocktwits
Topics Government
Exposures Political
Top S&P500 movers in Monday's pre-market session
Via Chartmill
S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform
Via Investor's Business Daily
Topics Government Stocks
Exposures Political US Equities
Mark Cuban Slams Charlie Kirk Over Drug Price Debate, Says PBMs — Not Big Pharma — Are The Real Villains: 'For Your Company...Ask Your PBM For A List Of Claims'
Via Benzinga

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 22.86
When was Pfizer last traded?
The last trade of Pfizer was at 05/19/25 11:03 AM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 128.20B
How many shares of Pfizer are outstanding?
Pfizer has 128B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.